UBS O'Connor’s Adient ADNT Stock Holding History

UBS O'Connor’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-100,000	Closed	-$1.73M	–	582
2020 Q3	$1.73M	Buy	+100,000	New	+$1.74M	0.04%	190

Other funds holding ADNT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LAM

Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

UBS O'Connor's ADNT Position: Q4 2020 in Review

UBS O'Connor sold out of Adient (ADNT) in Q4 2020, closing a stake of 100,000 shares — an estimated $1.73M sold.

UBS O'Connor first reported a position in ADNT in Q3 2020 and held it in 1 quarter. The position peaked at $1.73M in Q3 2020. 299 funds tracked by Wall St. Rank hold ADNT as of Q4 2020.

UBS O'Connor reported no remaining Adient position as of Q4 2020 after selling out during the quarter.
UBS O'Connor sold 100,000 Adient shares in Q4 2020, an estimated $1.73M.
UBS O'Connor first reported a position in Adient in Q3 2020 and held it in 1 quarter.
UBS O'Connor's Adient position peaked at $1.73M in Q3 2020.
299 funds tracked by Wall St. Rank held Adient as of Q4 2020.

Based on UBS O'Connor's 13F filing for Q4 2020, filed 17 Feb 2021.